By Business/Source
Currency:USD
2024/FY
Stock NameRevenueRatio
Research and development of immunotherapies and vaccines14.97M100.00%
By Country/Region
Currency:USD
2024/FY
Stock NameRevenueRatio
United Kingdom14.97M100.00%